Processing Environment for astatine-211 (At-211) (2026-UWMSN-01348-RFP).

The University of Wisconsin-Madison is soliciting proposals for a Processing Environment designed specifically for astatine-211, a radioisotope used in targeted alpha therapy research. The solicitation, identified as 2026-UWMSN-01348-RFP, was posted on July 20, 2026, with a firm response deadline of August 3, 2026, at 2:00 PM. All submissions must be submitted electronically through the SciQuest platform at the designated URL, and no other forms of response will be accepted. The requirement is for a specialized system capable of safely handling, processing, and containing astatine-211, which demands high levels of radiation shielding, contamination control, and operational precision in alignment with laboratory and regulatory standards. The procurement is part of the SLED category, with UW-Madison acting as the procuring agency in Wisconsin. The place of performance is within the state of Wisconsin, and inquiries must be directed exclusively to Carla Parker at carla.parker@wisc.edu. Although the point of contact listed includes Beth Battista as the primary contact, all communication must go through Carla Parker to be considered valid. There is no set-aside classification specified, and no NAICS code is provided, indicating this is a general procurement for advanced scientific equipment. The procurement portal and bid details are accessible via the provided vendor network link, and respondents are expected to fully comply with all technical and procedural requirements outlined in the online solicitation materials.